Tommy Nguyen, MD, PhD
Tommy Nguyen has over thirteen years of experience in biomedical research and finance. Tommy joined Sofinnova as a Senior Analyst in 2014 and is focused on identifying fundamentally sound private and public investments in therapeutics companies. Prior to joining Sofinnova Ventures, Tommy was part of the buy-side therapeutics team at the investment manager Jennison Associates and covered biotech stocks on the sell-side at Jefferies and Piper Jaffray. His historic areas of expertise include cardiometabolic disorders, oncology, HIV/HCV, men’s/women’s health, and inflammatory diseases.
Prior to Wall Street, Tommy trained in internal medicine and a cardiology fellowship at New York-Presbyterian Hospital, where he was awarded a New York Academy of Medicine’s Glorney-Raisbeck Fellowship in Cardiovascular Disease. He graduated with a BA in chemistry magna cum laude from Harvard. Tommy received his MD and PhD in molecular and cellular biology from the Tri-Institutional program of Cornell Medical College/ Memorial Sloan-Kettering Cancer Center/ Rockefeller University through the NIH Medical Scientist Training Program. He hails from New Orleans and Saigon and enjoys tennis and hi-fi audio equipment.